• 

  A Stem Cell Therapy for Parkinson’s Disease Heads to Phase 3 Trials
• 

  Alzheimer’s Drug Trials: Do Drug Companies Warn You About Your Genetic Risk?
• 

  In Trials: A Powerful Magnet for Zapping Alzheimer’s Away
• 

  Alzheon Alzheimer’s Pill Misses the Mark in Phase 3 Trial, Hints at Benefit in MCI
• 

  A Sensory Stimulation Headset for Alzheimer’s? A Neuropsychologist on the Clinical Trial
• 

  Remternetug: Alzheimer’s Prevention Trial Enrolls People as Young as 18
• 

  TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2025.01)
• 

  AHEAD Study Trial Participant Shares His Experience
• 

  ‘Unsettling:’ Federal DEI Ban a ‘Step Backward’ for Alzheimer’s Trials
• 

  Some Trial Volunteers Had Higher Risk of Brain Bleeds. Here’s Why Drugmakers Didn’t Tell Them
• 

  How Bad Is Fraud in Alzheimer’s Research? Q&A With Neurologist-Sleuth Matthew Schrag
• 

  TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2024.03)
• 

  Online Studies for Caregivers: A Participant Shares His Story
• 

  A Round-up of Alzheimer’s Drug Trials News From CTAD 2024

• Athira’s Alzheimer’s Drug Fails in Later-stage Clinical Trial

Previous123Next